ELUT
Price
$1.88
Change
-$0.13 (-6.47%)
Updated
Sep 5 closing price
Capitalization
79.7M
71 days until earnings call
PDEX
Price
$38.19
Change
-$7.55 (-16.51%)
Updated
Sep 5 closing price
Capitalization
124.57M
53 days until earnings call
Interact to see
Advertisement

ELUT vs PDEX

Header iconELUT vs PDEX Comparison
Open Charts ELUT vs PDEXBanner chart's image
Elutia
Price$1.88
Change-$0.13 (-6.47%)
Volume$202.02K
Capitalization79.7M
Pro-Dex
Price$38.19
Change-$7.55 (-16.51%)
Volume$90.75K
Capitalization124.57M
ELUT vs PDEX Comparison Chart in %
Loading...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELUT vs. PDEX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a StrongBuy and PDEX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ELUT: $1.88 vs. PDEX: $38.19)
Brand notoriety: ELUT and PDEX are both not notable
ELUT represents the Medical/Nursing Services, while PDEX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELUT: 539% vs. PDEX: 211%
Market capitalization -- ELUT: $79.7M vs. PDEX: $124.57M
ELUT [@Medical/Nursing Services] is valued at $79.7M. PDEX’s [@Pharmaceuticals: Other] market capitalization is $124.57M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 0 FA rating(s) are green whilePDEX’s FA Score has 0 green FA rating(s).

  • ELUT’s FA Score: 0 green, 5 red.
  • PDEX’s FA Score: 0 green, 5 red.
According to our system of comparison, PDEX is a better buy in the long-term than ELUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 4 TA indicator(s) are bullish while PDEX’s TA Score has 4 bullish TA indicator(s).

  • ELUT’s TA Score: 4 bullish, 5 bearish.
  • PDEX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ELUT is a better buy in the short-term than PDEX.

Price Growth

ELUT (@Medical/Nursing Services) experienced а -17.54% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -18.54% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

ELUT is expected to report earnings on Nov 17, 2025.

PDEX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDEX($125M) has a higher market cap than ELUT($79.7M). PDEX YTD gains are higher at: -18.310 vs. ELUT (-49.733). PDEX has higher annual earnings (EBITDA): 14.4M vs. ELUT (-14.01M). PDEX has more cash in the bank: 9.89M vs. ELUT (8.5M). PDEX has less debt than ELUT: PDEX (19.1M) vs ELUT (28.2M). PDEX has higher revenues than ELUT: PDEX (64.1M) vs ELUT (23.7M).
ELUTPDEXELUT / PDEX
Capitalization79.7M125M64%
EBITDA-14.01M14.4M-97%
Gain YTD-49.733-18.310272%
P/E RatioN/A14.30-
Revenue23.7M64.1M37%
Total Cash8.5M9.89M86%
Total Debt28.2M19.1M148%
FUNDAMENTALS RATINGS
PDEX: Fundamental Ratings
PDEX
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELUTPDEX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHBGF0.30N/A
N/A
CHINA BOTON GROUP CO LTD.
BYDIF5.19N/A
N/A
Byd Electronic International Co Ltd.
ETCIA0.01N/A
N/A
Electronic Tele-Communications, Inc.
NCTKF15.81N/A
N/A
Nabtesco Corp.
QNTO10.15N/A
N/A
Quaint Oak Bancorp, Inc.

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and PDEX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and PDEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
-6.47%
PDEX - ELUT
23%
Poorly correlated
-16.51%
SMTI - ELUT
23%
Poorly correlated
-1.38%
TWST - ELUT
23%
Poorly correlated
+0.51%
HSDT - ELUT
22%
Poorly correlated
-0.92%
CDNA - ELUT
22%
Poorly correlated
+5.50%
More

PDEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDEX has been loosely correlated with LMAT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PDEX jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-16.51%
LMAT - PDEX
38%
Loosely correlated
+0.43%
LDXHF - PDEX
26%
Poorly correlated
-9.52%
TCMD - PDEX
25%
Poorly correlated
+0.30%
WAT - PDEX
23%
Poorly correlated
+2.21%
ESTA - PDEX
23%
Poorly correlated
+0.93%
More